Filter Articles
Patient and Caregiver Preferences on CIDP Treatment
Patient and Caregiver Preferences on CIDP Treatment A research team is looking for patients and…
CIDP Patient Perspectives on IG Treatment
CIDP Patient Perspectives on IG Treatment A research team is looking for participants for a…
Adaptive Devices, New Patient-Reported Product List
Adaptive Devices, New Patient-Reported Product List LIFE with Peripheral Neuropathy just got a little easier...…
Self-Care for CarePartners: What? Why? How?
Self-Care for CarePartners: What? Why? How? On our website, the Foundation reminds GBS|CIDP CarePartners that…
GBS CIDP Foundation International Earns Coveted 4-Star Rating From Charity Navigator
Conshohocken, PA (June 2022) - GBS|CIDP Foundation International’s strong financial health and commitment to accountability…
Congress Recognizes the month of May as GBS|CIDP Awareness Month
On May 27, Congressman Garamendi, recognized the Month of May as GBS|CIDP AWARENESS Month and…
Sanofi Clinical Trial – CIDP Patients
A Phase 2 clinical study in adult patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Sanofi…
Announcing 2022 Benson Fellowship Awardee
Announcing 2022 Benson Fellowship Awardee, Elba Pascual Goñi MD, PhD The Benson Fellowship is a…
Pfizer-BioNTech COVID-19 Vaccine for children ages 5 through 11 years
On October 29, 2021, the U.S. Food and Drug Administration authorized the emergency use of…
Adapt. Adjust. Accept.
Highlights from Adaptive Devices Ask the Experts Videocast “My devices enable me to attain self-sufficiency…
Navigating Insurance Reimbursement in CIDP: Commercial Insurance or Medicare
Navigating Insurance Reimbursement in CIDP: Commercial Insurance or Medicare Join us as we explore the…
Medicare B will cover an immunoglobulin therapy for patients with CIDP, starting July 18, 2021
A message from our industry partners at CSL Behring: We are pleased to share that…
Angela’s Adaptive Devices
Written by Angela Patton Angela Patton is a member of GBS|CIDP’s Advisory Committee. In 2017,…
FDA Warning for Guillain–Barre Syndrome and the Johnson & Johnson COVID-19 Vaccine
A Statement from the Foundation Global Medical Advisory Board The Washington Post and New York…
In response to CBP preventing Mexican nationals from donating blood plasma
June 30, 2020 By Lisa Butler, Executive Director GBS|CIDP Foundation International Imagine the shock and…